Regional Observation of the Metabolic Syndrome

Completed

• Conditions: Metabolic Syndrome

• Registration Number: NCT00874952
• Lead Sponsor: AstraZeneca

Brief Summary

The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a regional basis, defined according to National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) guidelines criteria.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03
• Study First Submitted: 2009-04-02
• Study First Submitted QC: 2009-04-02
• Study First Posted: 2009-04-03
• Status Verified: 2010-02
• Primary Completion: 2010-02
• Study Completion: 2010-02
• Last Update Submitted: 2010-02-16
• Last Update Posted: 2010-02-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

• Signed informed consent
• Laboratory analysis (lipidic profile and glycemia) performed in the last year

Exclusion Criteria

• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
• Pregnancy or breast feeding
• Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of metabolic syndrome in primary care population	At visit
Concomitant presence of other cardiovascular (CV) risk factors.	At visit

Trial Locations

Locations (1)

Research Site; 🇮🇹 Torino, Italy